Trials / Completed
CompletedNCT05024006
Public Health Emergency: SOLIDARITY TRIAL Philippines
An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care Philippines
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,314 (actual)
- Sponsor
- University of the Philippines · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is an adaptive, randomized, open-label, controlled clinical trial utilizing an adaptive design to compare effects of repurposed drugs with local standard of care alone on major inpatient hospital outcomes. This is performed worldwide in collaboration with WHO.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remdesivir | Two intravenous loading doses, then daily infusion for 10 days |
| DRUG | Hydroxychloroquine | Two oral loading doses, then orally twice daily for 10 days |
| DRUG | Lopinavir / Ritonavir | Orally twice daily for 14 days |
| DRUG | Interferon beta-1a | Daily injection for 6 days |
| DRUG | Acalabrutinib | Orally twice daily for 10 days |
Timeline
- Start date
- 2020-04-23
- Primary completion
- 2021-04-17
- Completion
- 2021-04-17
- First posted
- 2021-08-27
- Last updated
- 2022-03-02
Locations
25 sites across 1 country: Philippines
Source: ClinicalTrials.gov record NCT05024006. Inclusion in this directory is not an endorsement.